KRAS and familial pancreatic carcinoma: Among HRAS, NRAS, and KRAS, KRAS is involved in the most frequently mutated oncogene in human cancers, accounting for approximately 25% of lung, 40% of colorectal, and 95% of pancreatic cancers [9].